Exome sequencing of Pakistani consanguineous families identifies 30 novel candidate genes for recessive intellectual disability by Riazuddin, S. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/181527
 
 
 
Please be advised that this information was generated on 2019-06-02 and may be subject to
change.
OPEN
ORIGINAL ARTICLE
Exome sequencing of Pakistani consanguineous families
identiﬁes 30 novel candidate genes for recessive intellectual
disability
S Riazuddin1,2,16, M Hussain1,3,4,5,16, A Razzaq3,4,5,16, Z Iqbal3,14,16, M Shahzad1,2, DL Polla3,6, Y Song7, E van Beusekom3, AA Khan5,
L Tomas-Roca3, M Rashid3,4,5, MY Zahoor5, WM Wissink-Lindhout3, MAR Basra5, M Ansar3,5,15, Z Agha3,8, K van Heeswijk3, F Rasheed5,
M Van de Vorst3, JA Veltman3,9, C Gilissen3, J Akram2, T Kleefstra3, MZ Assir4, UK10K10, D Grozeva11, K Carss12, FL Raymond11,
TD O’Connor7, SA Riazuddin13, SN Khan5, ZM Ahmed1, APM de Brouwer3, H van Bokhoven3,17 and S Riazuddin2,4,17
Intellectual disability (ID) is a clinically and genetically heterogeneous disorder, affecting 1–3% of the general population. Although
research into the genetic causes of ID has recently gained momentum, identiﬁcation of pathogenic mutations that cause autosomal
recessive ID (ARID) has lagged behind, predominantly due to non-availability of sizeable families. Here we present the results of
exome sequencing in 121 large consanguineous Pakistani ID families. In 60 families, we identiﬁed homozygous or compound
heterozygous DNA variants in a single gene, 30 affecting reported ID genes and 30 affecting novel candidate ID genes. Potential
pathogenicity of these alleles was supported by co-segregation with the phenotype, low frequency in control populations and
the application of stringent bioinformatics analyses. In another eight families segregation of multiple pathogenic variants was
observed, affecting 19 genes that were either known or are novel candidates for ID. Transcriptome proﬁles of normal human brain
tissues showed that the novel candidate ID genes formed a network signiﬁcantly enriched for transcriptional co-expression
(Po0.0001) in the frontal cortex during fetal development and in the temporal–parietal and sub-cortex during infancy through
adulthood. In addition, proteins encoded by 12 novel ID genes directly interact with previously reported ID proteins in six known
pathways essential for cognitive function (Po0.0001). These results suggest that disruptions of temporal parietal and sub-cortical
neurogenesis during infancy are critical to the pathophysiology of ID. These ﬁndings further expand the existing repertoire of genes
involved in ARID, and provide new insights into the molecular mechanisms and the transcriptome map of ID.
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INTRODUCTION
Intellectual disability (ID) is a common neurodevelopmental
disorder with an onset of cognitive impairment before the age of 18
years1–3 and is characterized by signiﬁcant limitations in intellectual
functioning and adaptive behavior.1 The disease affects 1–3% of the
world population; however, its prevalence in the developing world
is almost twice that of the afﬂuent world.4,5 The causes of nearly
40% of ID remain ambiguous.6 Among the known causes, ~ 50% of
ID cases have an environmental etiology such as poor nutrition,
multiple pregnancies with little gap, prenatal/perinatal brain
ischemia, postnatal infections and inadequate medical services.
The other half of ID cases has a genetic etiology, such as
chromosomal abnormalities or mutations in speciﬁc genes.3,5
In the western world, de novo heterozygous mutations and
genomic copy number changes account for the majority of ID
cases.7 In contrast, recessive ID appears to be more common in
consanguineous populations. Identiﬁcation of gene mutations that
cause non-syndromic autosomal recessive ID (ARID) has been
notoriously slow because of the scarcity of sizeable families. By 2006,
only three genes, CC2D1A, CRBN and PRSS12 had been associated
with ARID.8–10 After 2006, research studies involving highly inbred
populations from North Africa, the Middle East and South East Asia,
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greatly accelerated the pace of identiﬁcation of gene mutations that
cause ARID. These studies were further augmented by the use of
next-generation sequencing. In 2011, Najmabadi et al.11 applied
targeted next-generation sequencing to 136 consanguineous Iranian
families, in which homozygosity mapping had previously identiﬁed a
locus, and reported 23 known and 50 new candidate ARID genes.
More recently, exome sequencing (ES) of 143 large consanguineous
Saudi Arabian families revealed 33 novel candidate genes involved
in different neurological disorders.12 These studies further high-
lighted the clinical and genetic complexity of ID and other
neurodevelopmental disorders. Intriguingly, not a single gene with
pathogenic variants emerged across various populations. Despite
this progress, a large number of potential pathogenic gene
mutations remain unidentiﬁed and warrant further studies in
extended families from communities with endogamy.
Consanguineous marriages are practiced by about 20% of the
human population, and the extent of consanguinity varies among
different citizenry in the world. The rate of consanguineous
marriages is 38% in Iran,13,14 over 40% in several Middle Eastern
countries15 and above 50% in Pakistan.16 The elevated level of
endogamy in Pakistan has led to the increased prevalence of
genetic disorders, including ARID, with an average of 1.1 cases of
severe ID and 6.2 cases of mild ID per 100 live births.17 The present
study is designed to identify pathogenic gene mutations that cause
ARID in the highly inbred population of Pakistan. In all, 121 families
of 8 different ethnicities, exhibiting recessive ID, were enrolled
mostly from the rural population of Pakistan. Through a systematic
exome-sequencing approach we have identiﬁed potential patho-
genic variants in 68 of these families: 30 families with a single
homozygous DNA variant affecting previously known ID genes and
another 30 families with a single homozygous or compound
heterozygous variants in novel candidate ID genes. In eight families
multiple homozygous variants were identiﬁed. We report the
phenotype–genotype relationships, the predicted pathogenicity of
the newly discovered candidate genes, their co-expression in
functional networks in the developing and adult human brain, and
possible involvement in various cellular processes.
MATERIALS AND METHODS
Family ascertainment and phenotype analysis
This study was approved by the Institutional Review Board of the Centre of
Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore,
Pakistan and the Medical Ethical Committee Arnhem-Nijmegen, The
Netherlands. The families of our cohort were obtained mainly from the
rural populations of all ﬁve provinces of Pakistan (Supplementary Tables S1
and S2). Written informed consents were obtained from healthy adult
subjects and the parents/legal guardians of minor subjects and ID patients.
Speciﬁc informed consent was obtained for showing images of patients
(Supplementary Figure S1). Participating individuals were evaluated with
medical history interviews, and ID-related phenotypic features of patients
were recorded. All affected individuals were clinically evaluated by both a
geneticist and a general medical practitioner, with particular attention to
neurological, morphological, ophthalmological, dermatological and skele-
tal symptoms. Photographs of the face and uncovered limbs were also
taken (Supplementary Figure S1). In some cases, magnetic resonance
imaging and computerized tomography scans were also obtained. A
description of developmental milestones was used to evaluate the severity
of ID.18 Only families with conﬁrmed existence of cognitive dysfunction in
the affected members were included in this study. Peripheral blood
samples were collected from participating subjects. Genomic DNA was
isolated following standard procedures.19
Exome sequencing and variant selection
Exome enrichment and high-throughput sequencing were performed at
the Radboudumc (Nijmegen, The Netherlands), The Wellcome Trust Sanger
Institute (Hinxton, as part of the UK10K study) and the University of
Maryland as previously described.20 Selection of high-quality, potentially
pathogenic variants was performed using seven major ﬁltration steps
(Supplementary Figure S2 and Supplementary Methods).
Sanger sequencing
ES results were conﬁrmed by Sanger sequencing. Primers for the
ampliﬁcation of the exons carrying variants were designed by using
Primer3 (ref. 21; Supplementary Tables S9 and S10).
Predicted involvement of candidate genes in cellular processes
and pathways
We researched the available literature and extracted all reported protein–
protein interactions involving the known and the newly identiﬁed ID
proteins and then entered them into a set of protein–protein interaction
networks via the STRING22 and MATISSE23 algorithms, which are included
in the EXPANDER package tools.24
Expression of candidate genes in the human brain
Brain expression analyses for new ARID genes were conducted using
existing data sets in the BrainSpan: Atlas of the Developing Human Brain.25
Normalized gene expression levels for 26 different brain tissues from 31
different developmental periods were obtained from the BrainSpan RNA-
seq data set v3 (http://brainspan.org) of the developing human brain.
Co-expression network analysis
Networks of functionally co-expressed genes were identiﬁed by using the
model of Gulsuner et al.26 Using the BrainSpan database, gene pairs are
deﬁned as connected if the absolute value of the Pearson’s correlation
coefﬁcient is 40.8 for their expression levels in different brain regions
(frontal cortex, temporal-parietal, sensory–motor and sub-cortical) and
different developmental stages (fetal, infancy to late childhood and
adolescence to adulthood), totaling 12 different networks. For each of
these networks the numbers of edges (connections) between each of the
novel ID genes was calculated. Random simulations of 10 000 replicates of
an equal number of genes randomly selected from the BrainScan database
were conducted to establish the signiﬁcance of the connections. This
provided a distribution of edges to estimate an empirical P-value for our
novel ID genes.
In addition, we also randomly selected genes from the BrainScan
database with an HGNC gene symbol, as well as at least one connection in
the temporal region network. We compared an equal number of genes in
this set with our ID genes that passed the same ﬁltering criterion, which
provided more conservative and consistent P-values.
RESULTS
Recruitment of families
We enrolled a cohort of 121 ID families with a likely autosomal
recessive inheritance pattern mostly from the rural areas of
Punjab, Sindh, Baluchistan, Khyber Pakhtoon Khawa and Northern
areas. The enrolled families comprise eight ethnic groups, namely
Punjabi (68.6%), Siraiki (10.8%), Pathan (9%), Urdu speaking (7.8%)
and others (Sindhi, Afghan, Baloch and Kashmiri (3.8%);
Supplementary Table S1). Every family had two or more affected
individuals (except PKMR51a) and 111 families had consangui-
neous unions, while in 74 families the affected individuals were
present in separate sibships (Supplementary Table S2).
Genetic analysis
Before ES, the presence of disease-causing copy number variations
was excluded by SNP microarray analysis (Affymetrix 250 K SNP
array or higher coverage). ES was carried out for DNA samples of
1–3 individuals per family. Selection of the nucleotide variants was
performed using the seven-tier ﬁltering strategy (Supplementary
Figure S2). Sanger sequencing conﬁrmed 359 candidate patho-
genic variants. Of these, 80 variants in 77 genes segregated with
the ID phenotype. There are six categories of evidence that we are
using in this study to support an assertion that a variant is
potentially pathogenic. These are (1) segregation analysis; (2)
either absence in the dbSNP142 database or a very low allele
frequency (o0.01) in the ExAC Browser database; (3) absence in
213 ethnically matched control individuals; (4) a CADD score420;
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Table 1. Variants identiﬁed in known genes for intellectual disability or related disorders
Family Gene Positiona Transcript cDNA mutationb Protein change Variation CADD score
v1.3
ExAC allele frequency
x10− 6
OMIM Phenotypec
PKMR08 GNE Chr9:36217445C4T NM_005476.5 c.2086G4A p.(Val696Met) Missense 32.0 1942 603824 D
PKMR29 POMT2 Chr14:77765840T4C NM_013382.5 c.881A4G p.(Tyr294Cys) Missense 27.9 0 607439 O
PKMR36 APTX Chr9:32984803delC NM_001195248.1 c.638delG p.(Arg213Leufs*15) Frameshift NA 8.238 606350 O
PKMR42 VPS13B Chr8:100654333C4T NM_017890.4 c.5590C4T p.(Gln1864*) Nonsense NA 0 607817 O
PKMR51a TSHR Chr14:81610687C4T NM_000369.2 c.2285C4T p.(Thr762Met) Missense 25.3 8.247 603372 D
PKMR61a SCN1A Chr2:166848284G4A NM_001165963.1 c.5501C4T p.(Ala1834Val) Missense 32 8.241 182389d O
PKMR79 AP4M1 Chr7:99704430delG NM_004722.3 c.1287delG p.(Arg429Serfs*15) Frameshift NA 0 602296 O
PKMR82 KCNA2 Chr1:111147212G4A NM_004974.3 c.193C4T p.(Arg65*) Nonsense NA 8.239 176262d C, inheritance
D
PKMR85 MED23 Chr6:131941859T4C NM_004830.3 c.506A4G p.(Tyr169Cys) Missense 24.6 0 605042 C
PKMR86 FRAS1 Chr4:79202579C4T NM_025074.6 c.1099C4T p.(Arg367Cys) Missense 24.4 43.14 607830 O
PKMR87 MAN2B1 Chr19:12763176C4G NM_000528.3 c.1928+1C4G p.(Phe642Phefs*2) Aberrant
splicing
NA 0 609458 O
PKMR97 MFSD2A Chr1:40431565C4T NM_001136493.2 c.632C4T p.(Thr211Met) Missense 33 8.239 614397 C
PKMR99 SYNE1 Chr6:152819877C4G NM_182961.3 c.939G4C p.(Lys313Asn) Missense 21.9 28.33 608441 D
PKMR102 ASPM Chr1:197087007C4T NM_018136.4 c.3977G4A p.(Trp1326*) Nonsense NA 8.255 605481 C
PKMR105 ZNF41 ChrX:47315776C4T NM_007130.2 c.94G4A p.(Val32Met) Missense 30 0 314995 O
PKMR115 SRD5A3 Chr4:56212560G4A NM_024592.4 c.57G4A p.Trp19* Nonsense NA 357.1 611715 C
PKMR119 PGAP1 Chr2:197710616T4C NM_024989.3 c.2276A4G p.(Tyr759Cys) Missense 23.6 16.57 611655 C
PKMR133 DOCK8 Chr9:286599G4A NM_203447.3 c.295G4A p.(Glu99Lys) Missense 25.9 247.3 611432 C
PKMR151 TMEM67 Chr8:94768056G4A NM_153704.5 c.274G4A p.(Gly92Arg) Missense 25.6 17.41 609884 O
PKMR152 WDR62 Chr19:36587982G4T NM_001083961.1 c.2520+1G4T p.(Leu840Leufs*95) Aberrant
splicing
NA 0 613583 C
PKMR184 SPG11 Chr15:44876109delA NM_025137.3 c.5769delT p.(Ser1923Argfs*28) Frameshift NA 41.18 610844 C
PKMR188 ASPA Chr17:3402260G4A NM_000049.2 c.820G4A p.(Gly274Arg) Missense 28.9 8.421 608034 C
PKMR193 ARL13B Chr3:93755508G4A NM_182896.2 c.599G4A p.(Arg200His) Missense 34 8.314 608922 C
PKMR212 ZFYVE26 Chr14:68268804_05delGA NM_015346.3 c.1630_1631delTC p.(Ser544Leufs*24) Frameshift NA 8.236 612012 C
PKMR216 AP4S1 Chr14:31539047A4G NM_007077.4 c.139-2A4G p.(Gln46Glnfs*85) Aberrant
splicing
NA 24.71 607243 C
PKMR224 MKKS Chr20:10393388delT NM_018848.3 c.775delA p.(Thr259Leufs*21) Frameshift NA 74.18 604896 C
PKMR242 WDR73 Chr15:85186864A4G NM_032856.3 c.974T4C p.(Phe325Ser) Missense 29.9 0 616144 O
PKMR264 FRY Chr13:32747633G4A NM_023037.2 c.2281G4A p.(Val761Ile) Missense 21.7 8.281 614818 O
PKMR281 GPT2 Chr16:46956326C4T NM_133443.3 c.1210C4T p.(Arg404*) Nonsense NA 33.31 138210 O
PKMR321 FLNA ChrX:153583356G4A NM_001110556.1 c.5054C4T p.Thr1685Met Missense 27.1 11.58 300017 C
Abbreviations: C, concordant; D, discordant; NA, not applicable; O, overlapping features. aChromosomal position according to GRCh37/hg19. bNovel mutations are written in bold font. cConcordance of the
observed phenotype with the phenotype reported in Online Mendelian Inheritance in Man (OMIM). dReported phenotypes show a dominant inheritance pattern, whereas the mutations reported here are
homozygous.
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Table 2. Novel candidate genes for intellectual disability
Family Ethnicity Genes Positiona Transcript cDNA mutation Protein change Variation Protein function CADD
score v1.3
ExAC allele
frequency x10− 6
PKMR24 Punjabi ZSCAN25 (ZNF498) Chr7:99219114A4G NM_145115.2 c.506A4G p.(Glu169Gly) Missense Zinc ﬁnger protein nucleic
acid binding
26.5 0
PKMR33 Punjabi DPH1 Chr17:1944817C4T NM_001383.3 c.1144C4T p.(Pro382Ser) Missense Diphthamide biosynthesis 32 8.515
PKMR40 Pathan DCTN2 Chr12:57929561T4G NM_001261412.1 c.173A4C p.(Lys58Thr) Missense Structural protein 26.8 8.484
PKMR43 Pathan METTL5 Chr2:170677663_64delTC NM_014168.3 c.344_345delGA p.(Arg115Asnfs*19) Frameshift Methyl transferase NA 0
PKMR45 Pathan TANGO2 (C22orf25) Chr22:20041047G4T NM_152906.5 c.353G4T p.(Gly118Val) Missense Transport and Golgi organization 29.4 0
PKMR64 Punjabi CAPN12 b Chr19:39230761_62delTT NM_144691.4 c.658_659delAA p.(Asn220Glnfs*25) Frameshift Cystine protease NA 795.1
PKMR66 Punjabi TBC1D8 Chr2:101652537G4A NM_001102426.1 c.1501C4T p.(Leu501Phe) Missense G-protein modulator 31.0 99.37
PKMR67 Punjabi MSS51 (ZMYND17) Chr10:75187870G4A NM_001024593.1 c.173C4T p.(Ser58Leu) Missense Zinc ﬁnger transcription factor 33.0 140.1
PKMR72 Punjabi MDGA2 Chr14:47343402T4C NM_001113498.2 c.2232A4G p.(Arg744Arg) Aberrant Splicing GPI anchor NA 52.83
PKMR98 Punjabi FMOD Chr1:203316893C4T NM_002023.4 c.506G4A p.(Arg169Gln) Missense Receptor 23.3 296.6
PKMR118 Punjabi C22orf31 Chr22:29454885C4G NM_015370.1 c.718G4C p.(Gly240Arg) Missense Unknown 28.6 0
PKMR142 Punjabi SMARCA1 ChrX:128657269C4T NM_139035.2 c.79G4A p.(Glu27Lys) Missense Component of NURF complex 22.1 35.55
PKMR153 Punjabi GPAA1 Chr8:145138854G4C NM_003801.3 c.527G4C p.(Trp176Ser) Missense Glycosylphosphatidylinositol 27.6 16.58
PKMR155 Kashmiri OR2A12 Chr7:143792562G4A NM_001004135.1 c.362G4A p.(Arg121Gln) Missense Olfactory receptor 24.1 16.57
PKMR159 Punjabi AACS Chr12:125612785A4G NM_023928.3 c.1388A4G; p.(Asn463Ser); Missense Acetoacetyl-Co synthetase 21.2 82.95
Chr12:125621351C4T c.1822C4T p.(Arg608Cys) Missense 34.0 198.1
PKMR164 Punjabi GGN Chr19:38877823G4A NM_152657.3 c.79C4T p.(Arg27Cys) Missense Germ cell speciﬁc gene 25.9 362.3
PKMR174 Siraki MEGF9 Chr9:123421769C4T NM_001080497.2 c.686G4A p.(Gly229Asp) Missense Receptor 26.8 59.54
PKMR195 Siraki WFDC1 Chr16:84360517G4A NM_021197.3 c.634G4A p.(Gly212Arg) Missense Protease inhibitor 24.2 65.89
PKMR198 Punjabi METTL4 Chr18:2554909G4T NM_022840.4 c.588C4A p.(Cys196*) Nonsense Methyl transferase NA 41.19
PKMR200 Siraiki UBE2J2 Chr1:1203295_96delTT NM_194315.1 c.77_78delAA p.(Lys26Argfs*30) Frameshift Ubiquitin protein ligase NA 0
PKMR206 Siraiki CCDC82 Chr11:96117539delC NM_024725.3 c.373delG p.(Asp125Ilefs*6) Frameshift Unknown NA 0
PKMR213 Siraiki Baloch TMEM222 Chr1:27657230G4A NM_032125.2 c.214G4A p.(Gly72Ser) Missense Transmembrane protein 34.0 8.237
PKMR215 Siraiki PUS7 chr7:105148870_71delTG NM_019042.3 c.89_90delCA p.(Thr30Lysfs*20) Frameshift Pseudouridylate synthetase NA 8.237
PKMR258 Punjabi AREL1 Chr14:75150203G4A NM_001039479.1 c.277C4T p.(His93Tyr) Missense Ubiquitin-protein ligase 23.1 1102
PKMR298 Punjabi SEPT6 ChrX:118797529T4C NM_145799.3 c.257A4G p.(Tyr86Cys) Missense Filament formation 26.4 11.41
PKMR318 Punjabi DUOX1 Chr15:45444197G4T NM_175940.2 c.3140G4T p.(Cys1047Phe) Missense Oxidase 22.9 16.59
PKMR320 Punjabi SLC7A10 Chr19:33700282_83dupA NM_019849.2 c.1372_1373dupA p.(Thr458Asnfs*71) Frameshift Transporter NA 16.49
PKMR325 Punjabi TM2D3 Chr15:102182749G4A NM_078474.2 c.677C4T p.(Thr226Met) Missense Cell death or proliferation 31.0 8.344
PKMR326 Pathan PRKAR2B Chr7:106797706G4T NM_002736.2 c.1060G4T p.(Ala354Ser) Missense Kinase modulator 32.0 8.247
PKMR396 Punjabi RGR Chr10:86008779G4A NM_002921.3 c.350G4A p.(Arg117His) Missense Retinal G-protein coupled
receptor
26.5 107.3
Abbreviations: GPI, Glycophosphatidylinositol; NA, Not Applicable. aChromosomal position according to GRCh37/hg19. bThis frameshift allele of CAPN12 has been documented in apparently healthy British–
Pakistani individual in a homozygous fashion.35
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(5) pathogenicity prediction by multiple in silico programs; and (6)
enrichment of loss-of-function (LOF) and potentially pathogenic
variants of known and novel ID genes in patients with ID as
compared with individuals with the non-ID phenotype (n = 213;
Supplementary Table S3).
Pathogenic variants identiﬁed in previously reported ARID genes
We identiﬁed 34 predicted pathogenic variants in 32 genes
previously associated with ID or related neurodevelopmental
disorders (Tables 1 and 3a; Supplementary Figures S3 and S6).
These variants include homozygous missense (n= 21), nonsense
(n= 5), frameshift (n= 5) and splice site variants (n= 3). Twenty-ﬁve
of these variants are novel (Tables 1 and 3a). All new variants
segregated with the disease and were either absent in dbSNP142
or had an allele frequency ⩽ 0.002 in the ExAC Browser27 (Tables 1
and 3a).
Most genes were found to be mutated in only one family,
suggesting a low incidence of founder mutations underlying ID in
the Pakistani population. Two genes, TMEM67 and FRAS1, which
carried different variants in two independent families (Tables 1
and 3a). Two families (PKMR61b and PKMR69) carry one
homozygous variant each in two unrelated but known ID genes.
PKMR61b has variants in TMEM67 and FGFR1 while PKMR69 has
variants in FRAS1 and EXOSC8 (Table 3a; Supplementary Figure S6).
No carriers of these variants, which were both predicted to be
damaging and disease causing, were detected in our population-
speciﬁc controls. Two families each harbored a variant in an
X-linked gene (ZNF41 and FLNA).
A comparison of the phenotypes of 34 variants in genes known
to cause ID shows that in most families the phenotype is similar to
the reported entity (Supplementary Table S4). Some deviations do
occur, which may result from variable effects of allelic mutations
or the effects of genetic modiﬁer variants, which may be
particularly relevant in populations with a high consanguinity
rate.28,29
Pathogenic variants identiﬁed in novel candidate ARID genes
In 30 families we identiﬁed plausible pathogenic variants affecting
a single gene that had not been previously implicated in ARID
(Table 2; Supplementary Figure S4). The majority of these changes
were missense variants (n= 23). In addition, we identiﬁed frame-
shift (n = 6), nonsense (n= 1) and splice site (n= 1) variants that
result in a truncated protein or are predicted to result in nonsense-
mediated RNA decay. None of the variants were found in 213
unrelated, ethnically matched control individuals, indicating that
they are not indigenous Pakistani polymorphisms. Clustal W
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) alignment of protein
sequences encompassing the missense variants showed that
most of the mutated amino acids are evolutionarily conserved
(Supplementary Figure S5). In 9 of the families there were no
notable clinical characteristics besides ID, whereas 21 families
exhibited syndromic forms of ID (Supplementary Table S5).
In family PKMR159 a compound heterozygous change was
detected in AACS and both variants have a frequency o0.0002 in
the ExAC database27 (Table 2). In silico programs support a
pathogenic nature of these variants, suggesting that both alleles
are pathogenic and may contribute to the ID phenotype. In family
PKMR72 a synonymous change (c.2232A4G, p.(Arg813Arg)) was
identiﬁed in MDGA2 in the acceptor splice site of exon 13, which is
predicted to affect splicing by three splice prediction programs
(NNSPLICE30, HSF31 and MaxEntScan32).
In eight families, variants in more than one gene were identiﬁed
(Tables 3a and 3b, ; Supplementary Figure S6). Four of these genes
have already been implicated in a neurological disease (TMEM67,
FGFR1, FRAS1 and EXOSC8), but most variants affect genes that
have not previously been connected to human disease pheno-
types. Of the 19 co-segregating variants, 18 are missense variantsT
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and 1 is a splice site mutation. The identiﬁcation of multiple
variants co-segregating with the disorder suggests the possible
existence of composite phenotypes (Supplementary Table S6),
which might be a relatively common phenomenon in consangui-
neous populations.
Next, to determine the functional effect of variants, especially
missense, on the secondary structure, stability and interactions of
novel candidate ID proteins, we performed in silico molecular
modeling using the HOPE and Pyre2 web-based programs. On the
basis of the amino-acid sequence and structural homology with
proteins with resolved crystal structures, we evaluated the effect
of novel missense alleles in new ID proteins (Supplementary
Figure S7). The identiﬁed variants are predicted to alter the
function of the encoded proteins through their effect (loss off
ionic interactions, loss of external interactions, de-stabilization of
the core or the provision of more rigidity) on the secondary
structure (Supplementary Figure S7).
Newly identiﬁed ARID proteins participate in essential regulatory
networks
Next, we applied Ingenuity Pathway Analysis33 to visualize the
interactions between the 485 previously reported ID proteins
(http://gfuncpathdb.ucdenver.edu/iddrc/iddrc/GeneQuest.php) and
our novel candidate ID genes to identify the biological path-
ways underlying the disease process. The overall analysis, which
includes physical interactions, co-expression, activation, inhibition
and protein–RNA interactions, suggests that most novel ARID
candidate proteins are part of already-established molecular ID
gene networks (Figure 1b). By taking only physical interactions
into account, we found the integration of several new ARID
candidate proteins in oxidative phosphorylation, mitochondrial
dysfunction, PTEN signaling and PPAR/RXR activation (Po0.0001;
Figure 1a).
Functional co-expression networks of ARID genes
To gain insight into the spatio-temporal expression pattern of the
new candidate ARID genes, we extracted the mRNAseq data from
the Allen Brain Atlas34 and analyzed the expression patterns in
developing and adult human brain tissues (Supplementary Tables
S7 and S8). All new candidate ARID genes are expressed in the
human brain from a very early development stage to adulthood
(Supplementary Table S8).
When examining the co-expression functional networks for our
genes from the BrainScan database, we ﬁnd that they are
signiﬁcantly (Bonferroni-corrected α⩽ 0.0042) co-expressed in
the adult brain in all four brain regions and that they are
signiﬁcantly (Bonferroni-corrected P-value o0.0001) co-expressed
in the temporal–parietal and sub-cortical regions from infancy to
late childhood (Figure 2a). The phenotype observed in most of our
ID families is established at birth, so to further evaluate co-
expression during embryonic stages, we re-examined the normal-
ized mRNAseq data at various post-conception weeks (p.c.w.). We
found signiﬁcant co-expression of ID genes in the frontal cortex
region from 12 p.c.w. onwards (Figure 2b). Later in embryonic
development (24–37 p.c.w.) ID genes are also co-expressed in the
temporal–parietal and sub-cortical regions (Figure 2b), which
persisted from infancy to late childhood (Figure 2a).
DISCUSSION
We report the results of ES in a cohort of 121 consanguineous
Pakistani families. Likely causative variants in known ID genes
were identiﬁed in 30 of these families. In addition, a single likely
pathogenic variant affecting genes not previously implicated in ID
was identiﬁed in 30 families, and 8 families had multiple variants
segregating with the ID phenotype (Figure 3). Replication of this
study in independent families is warranted to add these genes toT
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the rapidly growing list of bona ﬁde genes implicated in ID. In fact,
during the submission phase of this manuscript-independent
mutations in ARID phenotypes were already reported for two
genes: DPH1 (ref. 35) and TANGO2.36,37 Other arguments that
strengthen the involvement of the candidate ID genes are the
disruptive nature of missense mutations as observed by modeling
of the protein structure (Supplementary Figure S7), the co-
occurrence of ARID candidate genes in common regulatory
pathways (Figure 1) and the co-expression of these genes in
distinct regions of the human brain (Figure 2). Further credit for
the involvement of the new candidate ID genes is provided by the
pattern of mutations. The frequency of predicted LOF alleles (that
is, nonsense, frameshift or splice site variants) in known ID genes is
13/34 (38.24%), whereas their occurrence for new candidate genes
is 8/30 (26.67%), and only 1/15 (6.67%) for candidate genes in
families with multiple segregating variants. These LOF variants in
the new candidate genes, METTL4, METTL5, CAPN12, MDGA2,
UBE2J2, CCDC82, PUS7, SLC7A10 and TBC1D23, have the highest
conﬁdence of causality. In addition, we analyzed the exomes of
213 unrelated Pakistani control individuals for variants affecting
the known ID genes and the novel candidate ID genes that we
have identiﬁed in our cohort. Importantly, homozygous and
compound heterozygous variants that would have passed our
stringent ﬁltering criteria were identiﬁed in eight different genes.
Five of these are known ID genes (APTX, ASPM, FLNA, POMT2 and
SYNE1), and only three are new candidate ID genes, of which two
were found in families with multiple segregating variants (ESYT3
and SLC45A4) and one affecting a gene (GGN) that harbored the
single segregating variant in the respective family. The relative
high occurrence of LOF alleles in families with single segregating
variants, as well as the paucity of predicted pathogenic variants in
these genes in a control cohort provides strong support for the
involvement of the candidate ID genes listed in Table 2.
Recently, ES of 3222 apparently healthy British adults of
Pakistani heritage revealed 1111 rare homozygous variants in
781 genes, including a frameshift allele (c.658_659delAA) in one of
the novel candidate genes CAPN12.38 No other homozygous LOF
allele was observed in any novel ID candidate gene. We found the
same frameshift allele (Table 2) segregating with a moderate ID
phenotype (Supplementary Table S5) in two affected individuals
of family PKMR64 (Supplementary Figure S4). There are at least
three possible reasons to explain these observations. First, the LOF
variant we identiﬁed in CAPN12 is not causative for the moderate
ID phenotype in family PKMR64, and CAPN12 should be discarded
as candidate ID gene. Second, without comprehensive assessment
of mental health it is hard to rule out that the British–Pakistani
individual has a mild ID phenotype similar to the phenotype in
family PKMR64. Indeed, there are indications to question the
health status of all individuals of the British–Pakistani cohort. For
example, the reported genetic variants include homozygous LOF
alleles in AHI1, C12orf57 and POMGNT1 genes, which are known to
underlie the severe neurological disorders, Joubert syndrome39,
Temtamy syndrome40 and muscle–eye–brain disease and other
muscular dystrophy–dystroglycanopathies,41 respectively. Variants
identiﬁed in the British–Pakistani adults also include LOF alleles in
GJB2, MYO3A and COCH genes, which are known to cause hearing
loss in humans.42–44 Third, there could be a protective or modiﬁer
genetic variant present in the British adult, which could render the
effect of c.658_659delAA allele of CAPN12.45,46
In the remaining 53 families, no high-conﬁdence DNA variants
was identiﬁed. This might be accounted for by several factors.
First, it is possible that some causative variants have not passed
our stringent ﬁltering criteria. Second, genetic heterogeneity is
likely to occur, even within some of the families we have studied.
Such phenocopies would disrupt the segregation of DNA variants
across all affected individuals in the studied pedigrees. Third, it is
possible that some of the phenotypes with mild to moderate ID
are caused by the digenic or oligogenic inheritance of rare
variants or polymorphisms with low effect size. Finally, some
mutations may have escaped detection by ES and may reside in
non-coding regions or regions poorly covered by exonic
enrichment.
Figure 1. (a) Protein–protein interactions of novel candidates in different pathways. Novel candidate genes either directly interact with known
intellectual disability (ID) genes (in blue) or through other genes (in gray) in the pathway. (b) Molecular functions of novel candidate genes (in
red) for ID are indicated. Genes are involved in various cellular processes by activating, inhibiting and interacting with other molecules and are
part of protein complexes.
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Intellectual disability and other neurodevelopmental disorders
There is a growing body of evidence that categorical neurodevelop-
mental disorders such as ID, autism spectrum disorders, attention
deﬁcit/hyperactivity disorders and learning disorders lack precise
boundaries in their clinical deﬁnitions, epidemiology, genetics, and
molecular and cellular networks.47–52 Accordingly, cognitive and
Figure 2. Co-expression of novel intellectual disability (ID) candidate genes was evaluated using RNA-seq data from the BrainSpan Atlas. (a) Gene
pairs were deﬁned as connected if the absolute value of the Pearson’s correlation coefﬁcient is40.8 for their expression levels in different brain
region (frontal cortex, temporal–parietal, sensory–motor and sub-cortical) and different developmental stage (fetal, infancy to late childhood and
adolescence to adulthood). Connections of co-expression genes at three development stages and four brain regions were plotted. Dotted lines
indicate numbers of connections (edges) in networks created using target genes. Histograms represent distributions of the numbers of edges in
10 000 simulated networks using a similar number of random genes. *Represents the signiﬁcance enrichment with P less than adjusted P-value.
(b) Co-expression of novel ID candidate genes during embryonic developmental stages for the same four brain regions.
Figure 3. Overview of the results of genetic studies in 121 consanguineous Pakistani families segregating recessive intellectual disability (ID)
phenotype.
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behavioral comorbidities such as attention deﬁcit/hyperactivity
disorders, speech delay and aggression are also frequently seen in
the ID families studied here. In our study, 21.88% of the families
(7 of 32) with mutations in known genes (Supplementary Tables S4
and S6) and 33.33% of the families (12 of 36) with variants in novel
candidate ARID genes resulting in clinical phenotypes that include
epilepsy (Supplementary Tables S5 and S6). These results are not
unexpected because the prevalence of epilepsy in individuals with
some degree of ID ranges from 5.5 to 35%.53 The prevalence of
epilepsy grows with increasing severity of ID, with 15% of
individuals with mild to moderate ID also exhibiting epilepsy and
more than 30% of those with severe ID.54 This high prevalence
underscores the importance of identifying largely unknown
common genetic factors with a causative role in epilepsy and ARID.
A striking example is provided by family PKMR82, in which a
homozygous nonsense mutation (p.Arg65*) in KCNA2 was asso-
ciated with mild to moderate ID, speech delay, strabismus, walking
delay and epilepsy. Recently, de novo KCNA2 missense mutations
were associated with epileptic encephalopathy, ataxia, variable
ID55,56 and other features reminiscent of those found in family
PKMR82. These de novo missense mutations exert dominant effects
by gain-of-function and dominant-negative mechanisms. The
nonsense mutation in PKMR82 represents the ﬁrst true LOF allele
of KCNA2, which apparently has no phenotypic consequences in
heterozygous mutation carriers.
Combinatorial ID phenotypes
We observed a syndromic ID phenotype in most of the studied
families (Supplementary Tables S4–S6). These syndromic ID
phenotypes could be attributed to the variant of a single gene
in most families, but we have also observed multiple indepen-
dently segregating variants in eight families (6.6%) of our cohort
(Tables 3a and 3b). This high co-occurrence of multiple potential
disease-causing alleles may lead to the occurrence of composite
recessive phenotypes. Both families PKMR61b and PKMR69 have
segregating variants in two independent known disease genes.
On the basis of the clinical presentation of previous mutations, in
families PKMR61b and PKMR69 it seems that the core phenotypic
features are attributable to just one of the two variants: TMEM67 in
family PKMR61b and EXOSC8 in family PKMR69. Such inferences
cannot be made for families in which segregating variants are
seen in multiple novel candidate ID genes. For example, in family
PKMR131 independent variants in ESYT3 and CCT6B are associated
with an unremarkable phenotype consisting of mild ID, speech
delay, slow learning and aggressive behavior. CCT6B and ESYT3
have not been connected to any human disorder so far, and
therefore the variants in either or both of these genes could
contribute to the phenotype.
Functional properties of novel ARID genes
A comprehensive evaluation of the transcriptome proﬁles of
normal human brain tissues revealed that the ID genes are signiﬁ-
cantly co-expressed in the frontal cortex region from 12 p.c.w.
onwards, and in the temporal–parietal and sub-cortical regions
from infancy to late childhood, implicating these regions in the
pathogenesis of ID. These brain regions incorporate external and
internal information and their disruptions have been associated
with various disorders, such as amnesia, Alzheimer’s disease and
schizophrenia,57 which further support the notion of shared
molecular networks between various brain disorders. At later
stages, we also found signiﬁcant co-expression in the frontal
cortex and sensory–motor regions (Figure 2a), which suggests that
many of the ID genes might also have an important role in
postnatal mechanisms, such as ﬁne-tuning of synaptic connectiv-
ity, circuitry formation, and acute synaptic and other neural
processes. Evidence for the involvement of postnatal mechanisms
in ID is provided by studies with conditional (postnatal) knockout
mice,58,59 as well as studies with postnatal interventions in ID
mouse models that are a basis of clinical trials for human ID
disorders, such as Fragile X syndrome, Down syndrome and
neuroﬁbromatosis.60–62
Common regulatory pathways involving new ARID genes
Only few of the novel ID genes seem to relate to molecular pathways
and networks that have been previously implicated in dominant and
X-linked forms of ID, such as pre- and post-synaptic signaling,
transcription regulation and epigenetic mechanisms.48,51,52 An
exception is UBE2J2, encoding a ubiquitin-conjugating enzyme,
which represents an emergent mechanism for regulating synapse
function by post-translational modiﬁcation through the ubiquitin
pathway at the postsynaptic membrane.63 Proteolysis by the
ubiquitin proteosome pathway is recognized as a major molecular
pathway leading to several neurodevelopmental48 and neurodegen-
erative diseases.64 Previously identiﬁed gene networks that are
commonly disrupted in ID and other neurodevelopmental disorders
are composed of genes that are highly dosage-sensitive. Thus, these
pathways might represent other neurobiological processes than
those that are affected by recessive mutations.
CONCLUSION
Our study demonstrates the clinical utility of consanguineous
populations for the elucidation of the molecular basis of very
heterogeneous recessive disorders. Uncovering candidate genes for
such disorders in inbred families will trigger the identiﬁcation of
matching mutations in other populations. In addition, a major
strength of the present study is the presentation of the clinical
proﬁles in conjunction with the reported candidate gene mutations.
Therefore, the large collection of data presented in this manuscript
is expected to facilitate the interpretation of DNA variants in
diagnostic exome studies of patients with difﬁcult-to-diagnose
neurodevelopmental disorders. Future work using model systems
may aid in unraveling and revealing the functional integration of
different molecular networks in normal brain development and
activity, which could add another level to neurological disorder
diagnosis and more effective targeted therapy.
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